Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Timing your first automated investment depends on savings goals and risk comfort; starting early can compound gains over time with steady contributions.
15,330 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
A new northwestern mutual 2025 study shows most Americans have no will, with Gen X and Baby Boomers lagging in estate...
In 2022, the S&P 500 tumbled as inflation hung over markets, but healthcare ETFs held up better. This piece examines ...
Astera Labs has captured investor attention with a strong rally. This article dives into the reasons behind the move,...
A veteran observer explains how AI upended the influencer economy, moving value from human brands to AI-assisted crea...
AI megacaps have powered the bulk of S&P 500 gains over the past two years. When AI-related stocks are stripped out, ...
Oil prices stayed contained as Beijing taps strategic stockpiles, a trend analysts say explains why crude hasn’t surg...
Geopolitical shocks often rattle heavy machinery stocks like Caterpillar. This guide breaks down the buy, sell, or ho...
As market conditions shift and living costs rise, households reexamine AD&D policies. This report explains why accide...
A bold $1.5 billion investment signals Boston Scientific’s shift into transcatheter aortic valve replacement. Explore...
SpaceX's planned NASDAQ debut includes two pivotal admissions that could influence investor risk assessments: Starshi...
An Ouster director recently disclosed an open-market sale of thousands of shares. This deep dive explains what such m...